Literature DB >> 10777705

Enhancement of S-nitrosylation in glycosylated hemoglobin.

J Padrón1, C Peiró, E Cercas, J L Llergo, C F Sánchez-Ferrer.   

Abstract

In this study, we report a novel differential nitric oxide interaction with nonglycosylated and glycosylated hemoglobin. After in vitro incubation of hemoglobin with S-nitroso N-acetyl penicillamine (SNAP), S-nitrosoglutathione, or S-nitrosocysteine, S-nitrosylation was significantly higher in human glycosylated hemoglobin purified from diabetic subjects compared to nondiabetic controls. Inversely, spontaneous decomposition was significantly lower for S-nitrosohemoglobin obtained from glycosylated hemoglobin. Bidimensional isoelectric focusing of hemoglobins incubated in vitro with SNAP also revealed a greater interaction of nitric oxide with glycosylated hemoglobin. In addition, a significantly higher level of S-nitrosohemoglobin was found in erythrocyte lysates from streptozotocin-induced diabetic rats compared to control rats. We suggest that highly glycosylated hemoglobin in diabetic subjects may favor S-nitrosylation, which may in turn impair vascular function, and participate in diabetic microangiopathy. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777705     DOI: 10.1006/bbrc.2000.2617

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  The transfusion problem: role of aberrant S-nitrosylation.

Authors:  James D Reynolds; Douglas T Hess; Jonathan S Stamler
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

Review 2.  Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease.

Authors:  Puneet Anand; Jonathan S Stamler
Journal:  J Mol Med (Berl)       Date:  2012-02-24       Impact factor: 4.599

3.  Inclusion of a nitric oxide congener in the insufflation gas repletes S-nitrosohemoglobin and stabilizes physiologic status during prolonged carbon dioxide pneumoperitoneum.

Authors:  Kazufumi Shimazutsu; Kenichiro Uemura; Kathryn M Auten; Matthew F Baldwin; Samuel W Belknap; Francisco La Banca; Maximilian C Jones; Deborah J McClaine; Rebecca J McClaine; W Steve Eubanks; Jonathan S Stamler; James D Reynolds
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

Review 4.  S-nitrosylation in cardiovascular signaling.

Authors:  Brian Lima; Michael T Forrester; Douglas T Hess; Jonathan S Stamler
Journal:  Circ Res       Date:  2010-03-05       Impact factor: 17.367

Review 5.  Regulation of cardiovascular cellular processes by S-nitrosylation.

Authors:  Ivonne Hernandez Schulman; Joshua M Hare
Journal:  Biochim Biophys Acta       Date:  2011-04-16

6.  S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood.

Authors:  James D Reynolds; Gregory S Ahearn; Michael Angelo; Jian Zhang; Fred Cobb; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-11       Impact factor: 11.205

7.  Repletion of S-nitrosohemoglobin improves organ function and physiological status in swine after brain death.

Authors:  Basil M Yurcisin; Tara E Davison; Syreena M Bibbs; Bradley H Collins; Jonathan S Stamler; James D Reynolds
Journal:  Ann Surg       Date:  2013-05       Impact factor: 12.969

8.  Hypoxic vasodilation by red blood cells: evidence for an s-nitrosothiol-based signal.

Authors:  Diana L Diesen; Douglas T Hess; Jonathan S Stamler
Journal:  Circ Res       Date:  2008-07-24       Impact factor: 17.367

Review 9.  Red Blood Cell-Mediated S-Nitrosohemoglobin-Dependent Vasodilation: Lessons Learned from a β-Globin Cys93 Knock-In Mouse.

Authors:  Richard T Premont; James D Reynolds; Rongli Zhang; Jonathan S Stamler
Journal:  Antioxid Redox Signal       Date:  2020-07-23       Impact factor: 8.401

10.  Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapy.

Authors:  Oluwatoyin Olatundun Ilesanmi
Journal:  Hematol Rep       Date:  2010-04-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.